DRIO
DarioHealth Corp
5.80$
-10.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.5% | +42.1% | -10.8% | -10.0% | +8.1% | -2.8% | -6.3% | +8.7% | -6.5% | -6.2% | -6.5% | |
| – | -15.8% | +10.9% | -25.1% | -24.9% | +37.3% | -4.9% | -16.6% | +31.1% | -17.5% | -18.2% | -22.3% | |
| – | -16.1% | -6.6% | -33.3% | -32.2% | +78.6% | +0.3% | -21.2% | +46.3% | -18.3% | -22.8% | -67.3% | |
| – | -16.1% | -6.6% | -33.3% | -32.2% | +83.1% | -2.1% | -21.2% | +46.3% | -18.3% | -22.8% | -29.7% | |
| – | -43.7% | +116.4% | +32.0% | -19.5% | -36.1% | +10.1% | -8.6% | -55.9% | +12.5% | -16.9% | -30.2% | |
| – | -7.5% | -2.9% | +4.4% | -7.6% | +0.2% | -2.8% | -0.3% | +5.6% | -11.4% | -3.3% | -10.9% | |
| – | +0.0% | +37.9% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -17.4% | +337.6% | -5.5% | -9.0% | -7.8% | -6.2% | -4.1% | -2.8% | -2.9% | -2.9% | -3.0% | |
| – | -0.6% | +54.1% | -8.2% | -4.9% | -8.9% | -10.6% | +5.8% | -3.5% | -1.5% | -3.0% | +1.5% | |
| – | +54.1% | +42.5% | -2.2% | +8.2% | -11.7% | +15.1% | -49.1% | -4.9% | +0.5% | +0.4% | +2.4% | |
| – | +3,316.0% | +19.9% | +24.6% | +52.5% | -35.7% | +81.1% | -95.3% | -13.3% | -2.7% | -12.1% | +51.3% | |
| – | -41.4% | +275.7% | -21.1% | -20.8% | +14.7% | -9.9% | +23.1% | +2.7% | -15.6% | +18.4% | -8.5% | |
| – | -15.2% | -0.3% | -4.4% | -13.9% | +16.3% | -19.5% | +61.4% | +0.4% | +0.4% | +0.6% | +0.4% | |
| – | -14.5% | +34.2% | -12.8% | -14.0% | +23.1% | +2.3% | -13.2% | +17.1% | -9.4% | -8.2% | -11.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.6% | +26.7% | +15.6% | +1.5% | +0.0% | +11.4% | +10.2% | +0.0% | +0.0% | +0.0% | -81.2% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.